News of the index components SPI

Index

SXGE

CH0009987501

Market Closed - Swiss Exchange 16:06:00 2026-07-03 EDT			5-day change	1st Jan Change
20,326.79 ^PTS	+0.59%		+1.87%	+11.57%

07-02	Swiss Blue-chip Index Recovers Amid Easing Inflation; UBS, Roche Shares Gain	MT
07-01	Swiss Market Index Blinks Red; Galderma Falls	MT

News of the index components

07-03	Swiss Stocks End Week Upbeat; Holcim Rises	MT
07-03	ABB signed a contract with Zhejiang Petroleum & Chemical in China
07-03	Jefferies slightly cuts its target on Sandoz
07-03	RBC Capital Downgrades Bucher Industries to Sector Perform, Cuts PT	MT
07-03	BofA Keeps Straumann at Buy Ahead of Q2 Results; Forecasts Nudged Higher	MT
07-03	Galderma Group Forecasts Revised as BofA Notes US FDA Response to Relfydess Application	MT
07-03	VAT Group Expands Partnership with Swiss Ice Hockey Club	MT
07-03	Givaudan Opens CHF50 Million Flavor Powders Production Facility in Indonesia	MT
07-03	Julius Baer Taps StanChart Interim CFO to Lead Finance	MT
07-03	Julius Baer appoints Peter Burrill as CFO	RE
07-03	Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment	MT
07-02	Aevis Victoria's Infracore Completes Purchase of Hospital Buildings in Switzerland	MT
07-02	Julius Baer Group Reportedly Set to Lift Ban on Certain Higher-risk Clients	MT
07-02	Swiss Blue-chip Index Recovers Amid Easing Inflation; UBS, Roche Shares Gain	MT
07-02	ABB Wins Order to Deliver Ethernet-APL Flowmeters for Chinese Refining, Petrochemical Complex	MT
07-02	UBS to Launch US Banking Services Trial for Staff in December	MT
07-02	UBS Capital Enough to Meet Proposed Banking Reforms, Swiss Central Bank Says	MT
07-02	UBS to Pilot US Banking Services for Employees Ahead of 2027 Wealth Client Launch	MT
07-02	SNB: UBS Capable of Complying with Switzerland's Planned Changes to Capital Rules	MT
07-02	Novartis Wins European Approval For Spinal Muscular Atrophy Gene Therapy	MT
07-02	Swiss National Bank: Stablecoins Pose 'Limited' Immediate Risk to Domestic Financial Stability	MT
07-02	'Absolutely No Sign' of Let Up in AI Demand, UBS Says	MT
07-02	BofA Expects 'Small' Novartis Q2 Consensus Miss, Unchanged FY26 Outlook; Buy Rating Kept	MT
07-02	Molecular Partners Doses First Patients in Lung Cancer Trial	MT
07-02	UBS has enough capital to satisfy planned Swiss reforms, central bank says	RE
07-02	Molecular Partners, Orano Med Dose First Patient in Small-Cell Lung Cancer Study	MT
07-02	Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial	DJ
07-02	Roche's Non-small Cell Lung Cancer Drug Meets Primary, Key Secondary Endpoint in Late-stage Trial	MT
07-02	UBS to Launch US Banking Services Trial for Staff in December	MT
07-02	Novartis Spinal Muscular Atrophy Treatment Receives European Commission Approval	MT
07-02	Novartis receives European Commission approval for Itvisma(R) for spinal muscular atrophy (SMA)	DJ
07-02	Swiss Life Germany Acquires Financial Adviser Telis Group	MT
07-02	Helvetia Baloise Wraps Up Merger of Swiss Insurance Companies	MT
07-02	Helvetia Baloise Combines Asset Management Units Via Universal Succession	MT
07-01	Health Care Up on AI Rotation - Health Care Roundup	DJ
07-01	Swiss Market Index Blinks Red; Galderma Falls	MT
07-01	ABB Closes Acquisition of Italian Transformer Manufacturer Specialtrasfo	MT
07-01	Galderma Hits FDA Setback Again in Bid to Launch Botox Rival in U.S. -- Update	DJ
07-01	Grupo Santander Downgrades CIE Financiere Richemont to Neutral, Lifts PT	MT
07-01	AlphaValue/Baader Europe Downgrades Julius Baer Group to Reduce, Trims PT	MT